| Harold A Small Dds Pa | |
|
3 S Main St Caldwell KS 67022-1531 | |
| (620) 845-6417 | |
| (620) 845-6422 |
| Full Name | Harold A Small Dds Pa |
|---|---|
| Speciality | Dentist |
| Location | 3 S Main St, Caldwell, Kansas |
| Authorized Official Name and Position | Harold Andrew Small (PRESIDENT) |
| Authorized Official Contact | 6208456417 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Harold A Small Dds Pa 3 S Main St Caldwell KS 67022-1531 Ph: (620) 845-6417 | Harold A Small Dds Pa 3 S Main St Caldwell KS 67022-1531 Ph: (620) 845-6417 |
| NPI Number | 1235111667 |
|---|---|
| Provider Enumeration Date | 11/21/2005 |
| Last Update Date | 08/22/2020 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235111667 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 6646 (Kansas) | Primary |
News Archive
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today announced that it has received a positive opinion for orphan medicinal product designation for its compound perifosine from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency, for the treatment of multiple myeloma.
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that it has received Notice of Allowance from the U.S. Patent and Trademark Office for its patent application "Abuse-Deterrent Drug Formulations", US Patent Application Number 11/149,867. The Notice of Allowance is the USPTO's official communication that the Company's application has successfully completed examination and that a patent will be issued.
"As an anti-hunger advocate, ... I am hopeful about the global change that President Obama could make in his second term, especially when it comes to reducing poverty, but I worry Congress might toss the hungry off the fiscal cliff," Katie Campbell, senior policy analyst with ActionAid U.S., writes in The Hill's "Congress Blog."
The Global Health Technologies Coalition's "Breakthroughs" blog examines "the likely devastating impact of sequestration on U.S.-funded global health, research, science, and development programs" and summarizes several recently released reports on potential budget cuts.
Researchers at Fred Hutchinson Cancer Research Center have opened a clinical trial to test the theory that giving a patient a new immune system can cure severe cases of Crohn's disease, a chronic inflammatory condition of the gastrointestinal tract.
› Verified 8 days ago